TrimRx's Blog

Introduction The current state of evidence as of 2026: no human data has linked semaglutide to increased cancer risk, and some studies show reduced…

Semaglutide changes several blood test results, and most of those changes are the point of the drug.

Yes, Ozempic mildly increases urination in many patients, especially during active weight loss.

The honest answer is no in the short term, yes in the medium term. Mounjaro (tirzepatide) is not a stimulant.

Introduction Medicare’s GLP-1 coverage in 2026 is a patchwork of yes, no, and “only if.” The short answer: Medicare covers GLP-1s for type 2…

Medicaid coverage of GLP-1 medications in 2026 depends entirely on your state and your diagnosis.

Introduction Kaiser Permanente operates as an integrated HMO across 9 regions: California (Northern and Southern), Colorado, Georgia, Hawaii, Maryland, Oregon, Virginia, Washington, and the…

Humana’s book of business is heavily Medicare Advantage and Medicare Part D, which shapes its GLP-1 coverage in a distinctive way.

Cigna runs its pharmacy benefit through Express Scripts. That single fact shapes everything else about GLP-1 coverage on Cigna plans.